Unity Biotechnology, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Unity Biotechnology, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2023.
  • Unity Biotechnology, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $1.2M, a 29.6% decline year-over-year.
  • Unity Biotechnology, Inc. annual Operating Lease, Payments for 2023 was $4.81M, a 23.4% decline from 2022.
  • Unity Biotechnology, Inc. annual Operating Lease, Payments for 2022 was $6.28M, a 5.56% decline from 2021.
  • Unity Biotechnology, Inc. annual Operating Lease, Payments for 2021 was $6.65M, a 14.8% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.2M -$504K -29.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 $1.7M +$52K +3.15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $1.65M +$813K +96.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $839K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.